On December 12, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on December 12, CITIC SEC Asset Management Co., Ltd. increased its shareholding by purchasing shares at an average price of 21.2531 HKD per share on December 11.$SINOPHARM (01099.HK)$2.8236 million shares of H-shares were acquired, valued at approximately 60.0103 million HKD. After the increase, CITIC SEC Asset Management Co., Ltd.'s latest shareholding stands at 0.108 billion shares, with the good warehouse ratio rising from 7.86% to 8.07%.
This trade involves other related parties: citic sec - Yunfan single asset management plan.
Additional information: The equity is held by citic sec asset management company on behalf of all the asset management plans it manages, disclosing the shares of sinopharm holdings limited - H share equity.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) must disclose their shareholding interests in listed companies. The Directors and senior executives of listed companies must disclose their share and debenture interests in both the listed company and its affiliated companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
